Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,143 | -6,480 |
| Depreciation Amortization | 20 | 40 |
| Accounts receivable | -113 | N/A |
| Accounts payable and accrued liabilities | -41 | N/A |
| Other Working Capital | -100 | 20 |
| Other Operating Activity | 2,137 | 2,930 |
| Operating Cash Flow | $761 | $-3,490 |
| Cash Flows From Investing Activities | ||
| PPE Investments | N/A | -3 |
| Investing Cash Flow | $N/A | $-3 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 0 | 5,020 |
| Financing Cash Flow | $0 | $5,020 |
| Beginning Cash Position | 2,155 | 620 |
| End Cash Position | 2,917 | 2,150 |
| Net Cash Flow | $761 | $1,520 |
| Free Cash Flow | ||
| Operating Cash Flow | 761 | -3,490 |
| Free Cash Flow | 761 | -3,490 |